PHILADELPHIA–(BUSINESS WIRE)– #benefits–LENSRXLAB, a leading provider of diabetic, safety, and dress eyewear, announces the launch of its Supplemental Vision Benefits Platform for Diabetics, aiming to revolutionize vision care. Founded by a Military…
Bausch + Lomb Announces Statistically Significant Results From a Clinical Study of a Novel Daily Nutritional Supplement for Dry Eyes
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced Frontiers in Ophthalmology published statistically significant res…
Uncategorized
Aldeyra Therapeutics Highlights Recent Preclinical Data in Obesity, Atopic Dermatitis, Pain, and Alcoholic Hepatitis, and Announces Planned Pivotal Clinical Trial in Retinitis Pigmentosa, at 2024 Research & Development Day
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) will host the Aldeyra 2024 Research & Development Day with investors and financial analysts in New York City to present recent pipeline developments relating to …
Uncategorized
Harrow Will Release First Quarter 2024 Financial Results After Market Close on May 13, 2024
NASHVILLE, Tenn.–(BUSINESS WIRE)—- $HROW–Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, today announced that it will release its financial results for the first quarter ended March 31, 2024, on Monday, May 13, 2024, after the…
Uncategorized
SCIENCE CORPORATION ACQUIERT L’IMPLANT RÉTINAL PRIMA DE PIXIUM, RENFORÇANT ET DIVERSIFIANT AINSI SON ENGAGEMENT EN FAVEUR DE LA RESTAURATION DE LA VISION GRÂCE À SA TECHNOLOGIE D'INTERFACE NEURONALE DIRECTE
ALAMEDA, CALIFORNIE–(BUSINESS WIRE)–Science Corporation (« Science »), leader de la technologie d’interface neuronale directe (« IND ») et développeur de Science Eye, a fait l’acquisition des droits de PI et des actifs associés pour l’implant rétinie…
Uncategorized
Science Corporation Acquires Pixium’s PRIMA Retinal Implant, Extending and Diversifying Its Commitment to Vision Restoration Through Brain-Computer Interface Technology
ALAMEDA, Calif.–(BUSINESS WIRE)–Science Corporation acquires Pixium’s PRIMA retinal implant, diversifying commitment to vision restoration